BELTSVILLE, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the publication of a review article in the online journal Frontiers in Immunology, highlighting the need for targeting… Read More..

As Part of Its Application the Company Has Provided Significant Data Related to Hazardous Incidents with Electrical Wire Installations. SKYX's Ceiling Outlet Receptacle Platform Enables a Safer, Fast, and Robust Plug and Play Installation of Light Fixtures, Ceiling Fans and Smart Home Products to Ceilings The Last Significant NEC Mandatory… Read More..

SKYX's Robust Patent Portfolio Now Totals 72 Patent and Pending Applications with 18 Issued Patents New Patents Issued Cover the SKYX All-In-One Smart Modular Platform, Which Includes Smart Home Technology and Home Safety Sensors MIAMI, FL / ACCESSWIRE / September 7, 2023 - SKYX Platforms Corp.(NASDAQ:SKYX) (d/b/a "Sky Technologies"), a… Read More..